The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Incubator/Accelerator | Alive

Total Raised


About GlakoLens

GlakoLens is a medical devices company developing biosensors based on proprietary technology, first of which is a wearable, continuous (24h) intra-ocular pressure (IOP) monitoring device for the (early) diagnosis and personalized management of ocular hypertension and management of glaucoma. GlakoLens’ product, GlakoSense Platform, is based on non-invasive biosensor technology that will enable continuous IOP monitoring for 24 hours. It is a complete monitoring system including sensor-incorporated contact lenses, readout/recording units, and data analytics service. Specifically, the product is comprised of an electrically passive sensor embedded in a comfortable disposable soft contact lens, and a wearable electronic system to take non-contact measurements from the sensor and to store the data. The placement of the disposable contact lens sensor and the wearable electronic system are carried out by trained medical staff in the clinic. The patient wears the products for 24 hours and returns to the clinic the next day, where the staff downloads the IOP fluctuation data from the device and deliver the results to the ophthalmologists for evaluation. GlakoSense Platform will enable the streamlined collection of previously unobtainable IOP fluctuation data that is also precious for scientific research. Additionally, it will become a valuable tool for the development of ocular hypertension drugs and associated clinical research.

GlakoLens Headquarter Location

Bogazici University Teknopark 306, Kuzey Campus Bebek Yolu Sok. 2/5 Rumelihisarustu

Istanbul, 34470,



Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing GlakoLens

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

GlakoLens is included in 3 Expert Collections, including Medical Devices.


Medical Devices

7,913 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

462 items

Companies developing wearable health monitoring solutions (human health only). Companies tagged as #Wearables (*note: this tag may also apply to companies outside the scope of this collection)


Health IT

7,900 items

GlakoLens Patents

GlakoLens has filed 1 patent.

The 3 most popular patent topics include:

  • Cardiac surgery
  • Contact lenses
  • Implants (medicine)
patents chart

Application Date

Grant Date


Related Topics



Metamaterials, Contact lenses, Resonator guitarists, Cardiac surgery, Implants (medicine)


Application Date


Grant Date


Related Topics

Metamaterials, Contact lenses, Resonator guitarists, Cardiac surgery, Implants (medicine)



Latest GlakoLens News

Glakolens Raises €465K in Seed Funding

May 25, 2017

ACT Venture Partners made the investment. The company will use the funds to focus on further refining, testing and then certifying the technology. Founded by the members of a research group at Boğaziçi University and led by Prof. Günhan Dündar, Dr. Arda Deniz Yalçınkaya and Dr. Hamdi Torun, Glakolens is advancing a novel non-invasive continuous intra-ocular pressure (IOP) diagnostics and monitoring device based on proprietary technology licensed from Boğaziçi University. The company’s strategy is to focus on introducing a product to address specific needs in ophthalmology where there is need for viable products. The IOP sensor developed by Glakolens is based on a novel non-invasive approach to very accurately diagnose and passively monitor fluctuations in IOP by measuring certain properties of the eye. The data is collected wirelessly over a period without going to the hospital and further processed using various protocols to offer insights. FinSMEs

GlakoLens Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

GlakoLens Rank

  • When was GlakoLens founded?

    GlakoLens was founded in 2017.

  • Where is GlakoLens's headquarters?

    GlakoLens's headquarters is located at Bogazici University Teknopark 306, Kuzey Campus, Istanbul.

  • What is GlakoLens's latest funding round?

    GlakoLens's latest funding round is Incubator/Accelerator.

  • How much did GlakoLens raise?

    GlakoLens raised a total of $1M.

  • Who are the investors of GlakoLens?

    Investors of GlakoLens include BIO Startup Program and ACT Venture Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.